A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

NCT02199678 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: Placebo
DRUG: ketamine 25 mg
DRUG: ketamine 35 mg
DRUG: ketamine 50 mg

Sponsor

Lotus Clinical Research, LLC

Collaborators

[object Object]